AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 281 min read$BLLN

Tsao David sold $1.0M of BLLN

Tsao David (Chief Technology Officer) sold 10,000 shares of BillionToOne, Inc. (BLLN) at $100.00 ($1.00M total) on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tsao David
Published Aug 28, 2026, 12:19 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The sale is modest and likely reflects a pre‑planned liquidity event rather than new negative information.

02

Market read

Routine insider sale with limited trading relevance.

03

Timing

post filing 2026-08-27

Relevance 5/10Novelty 4/10Timing: post filing 2026-08-27

Background

SEC Form 4 filing discloses insider transaction for BillionToOne, Inc.

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

CTO sold 10,000 shares for $1,000,000 via a 10b5-1 plan, reducing holdings to 1,000 shares.

Expected impact

Potential slight downward pressure, unlikely to move price materially.

Evidence & confidence

The $1M sale is a routine 10b5-1 transaction; impact limited by small share count and low float.

Market effects

Sector

None

Regional

None

Global

None

Key entities

  • Company
    BillionToOne, Inc.

    Issuer of the Form 4 filing.

  • Insider
    Tsao David

    Chief Technology Officer who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BLLN insider trading history →

Related articles

AUG 6
$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

benzinga.com3 min
MAY 27
$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.

dailypolitical.com1 min